Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 Dec;85(24):9788–9791. doi: 10.1073/pnas.85.24.9788

Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.

M S Bryant 1, P Vineis 1, P L Skipper 1, S R Tannenbaum 1
PMCID: PMC282866  PMID: 3200858

Abstract

Hemoglobin adducts of 15 aromatic amines were determined in nonsmokers and smokers of blond- or black-tobacco cigarettes living in Turin, Italy. The subjects were all males age 55 or less and were representative of the population previously examined in a case/control study of bladder cancer. 4-Aminobiphenyl adduct levels were found to be significantly different in the three groups, and the differences were approximately proportional to the relative risk of each group. Adjustment for age and cigarette consumption did not materially influence the differences. A significant correlation of adduct levels with cigarette consumption was also observed for all smokers as well as for smokers of blond tobacco. Other amines for which significant differences between smokers and nonsmokers were observed were 3-aminobiphenyl, 2-naphthylamine, o- and p-toluidine, 2,4-dimethylaniline, and 2-ethylaniline. Some of these amines are human bladder carcinogens, and their occurrence in blood as hemoglobin adducts is evidence for their metabolic activation. Thus, by a combination of traditional epidemiological methods and modern chemical analyses, we have provided evidence for a biochemical basis for the often observed association between cigarette smoking and bladder cancer.

Full text

PDF
9788

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bryant M. S., Skipper P. L., Tannenbaum S. R., Maclure M. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res. 1987 Jan 15;47(2):602–608. [PubMed] [Google Scholar]
  2. Everson R. B., Randerath E., Santella R. M., Cefalo R. C., Avitts T. A., Randerath K. Detection of smoking-related covalent DNA adducts in human placenta. Science. 1986 Jan 3;231(4733):54–57. doi: 10.1126/science.3941892. [DOI] [PubMed] [Google Scholar]
  3. Farmer P. B., Neumann H. G., Henschler D. Estimation of exposure of man to substances reacting covalently with macromolecules. Arch Toxicol. 1987 Jun;60(4):251–260. doi: 10.1007/BF01234663. [DOI] [PubMed] [Google Scholar]
  4. Garner R. C. Assessment of carcinogen exposure in man. Carcinogenesis. 1985 Aug;6(8):1071–1078. doi: 10.1093/carcin/6.8.1071. [DOI] [PubMed] [Google Scholar]
  5. Green L. C., Skipper P. L., Turesky R. J., Bryant M. S., Tannenbaum S. R. In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin. Cancer Res. 1984 Oct;44(10):4254–4259. [PubMed] [Google Scholar]
  6. Harris C. C., Vahakangas K., Newman M. J., Trivers G. E., Shamsuddin A., Sinopoli N., Mann D. L., Wright W. E. Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6672–6676. doi: 10.1073/pnas.82.19.6672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hartge P., Silverman D., Hoover R., Schairer C., Altman R., Austin D., Cantor K., Child M., Key C., Marrett L. D. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst. 1987 Jun;78(6):1119–1125. [PubMed] [Google Scholar]
  8. Haugen A., Becher G., Benestad C., Vahakangas K., Trivers G. E., Newman M. J., Harris C. C. Determination of polycyclic aromatic hydrocarbons in the urine, benzo(a)pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Res. 1986 Aug;46(8):4178–4183. [PubMed] [Google Scholar]
  9. Kadlubar F. F., Miller J. A., Miller E. C. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res. 1977 Mar;37(3):805–814. [PubMed] [Google Scholar]
  10. Lewalter J., Korallus U. Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring. Int Arch Occup Environ Health. 1985;56(3):179–196. doi: 10.1007/BF00396596. [DOI] [PubMed] [Google Scholar]
  11. Lower G. M., Jr, Nilsson T., Nelson C. E., Wolf H., Gamsky T. E., Bryan G. T. N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ Health Perspect. 1979 Apr;29:71–79. doi: 10.1289/ehp.792971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Perera F. P. Molecular cancer epidemiology: a new tool in cancer prevention. J Natl Cancer Inst. 1987 May;78(5):887–898. [PubMed] [Google Scholar]
  13. Perera F. P., Santella R. M., Brenner D., Poirier M. C., Munshi A. A., Fischman H. K., Van Ryzin J. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers. J Natl Cancer Inst. 1987 Sep;79(3):449–456. [PubMed] [Google Scholar]
  14. Poupko J. M., Hearn W. L., Radomski J. L. N-Glucuronidation of N-hydroxy aromatic amines: a mechanism for their transport and bladder-specific carcinogenicity. Toxicol Appl Pharmacol. 1979 Sep 30;50(3):479–484. doi: 10.1016/0041-008x(79)90401-0. [DOI] [PubMed] [Google Scholar]
  15. Schifflers E., Jamart J., Renard V. Tobacco and occupation as risk factors in bladder cancer: a case-control study in southern Belgium. Int J Cancer. 1987 Mar 15;39(3):287–292. doi: 10.1002/ijc.2910390304. [DOI] [PubMed] [Google Scholar]
  16. Stillwell W. G., Bryant M. S., Wishnok J. S. GC/MS analysis of biologically important aromatic amines. Application to human dosimetry. Biomed Environ Mass Spectrom. 1987 May;14(5):221–227. doi: 10.1002/bms.1200140505. [DOI] [PubMed] [Google Scholar]
  17. Tannenbaum S. R., Skipper P. L. Biological aspects to the evaluation of risk: dosimetry of carcinogens in man. Fundam Appl Toxicol. 1984 Jun;4(3 Pt 2):S367–S373. doi: 10.1016/0272-0590(84)90264-1. [DOI] [PubMed] [Google Scholar]
  18. Törnqvist M., Osterman-Golkar S., Kautiainen A., Jensen S., Farmer P. B., Ehrenberg L. Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis. 1986 Sep;7(9):1519–1521. doi: 10.1093/carcin/7.9.1519. [DOI] [PubMed] [Google Scholar]
  19. Vineis P., Estève J., Terracini B. Bladder cancer and smoking in males: types of cigarettes, age at start, effect of stopping and interaction with occupation. Int J Cancer. 1984 Aug 15;34(2):165–170. doi: 10.1002/ijc.2910340205. [DOI] [PubMed] [Google Scholar]
  20. Wogan G. N., Gorelick N. J. Chemical and biochemical dosimetry of exposure to genotoxic chemicals. Environ Health Perspect. 1985 Oct;62:5–18. doi: 10.1289/ehp.85625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zhu J. Q., Zhang L. S., Hu X., Xiao Y., Chen J. S., Xu Y. C., Fremy J., Chu F. S. Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine. Cancer Res. 1987 Apr 1;47(7):1848–1852. [PubMed] [Google Scholar]
  22. el-Bayoumy K., Donahue J. M., Hecht S. S., Hoffmann D. Identification and quantitative determination of aniline and toluidines in human urine. Cancer Res. 1986 Dec;46(12 Pt 1):6064–6067. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES